Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGD | P52209 | 3/20 | 0.53 |
| ▸ | MPI | P34949 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | PGK1 | P00558 | 1/20 | 0.47 |
| ▸ | PGK2 | P07205 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL939456 | 1.00 | PGD (0.53) | PGDMPILMNAL3MBTL1PGK1 | |
| SCHEMBL3515615 | 1.00 | PGD (0.53) | PGDMPILMNAL3MBTL1PGK1 | |
| SCHEMBL1533840 | 1.00 | PGD (0.53) | PGDMPILMNAL3MBTL1PGK1 | |
| SCHEMBL428503 | 1.00 | PGD (0.53) | PGDMPILMNAL3MBTL1PGK1 | |
| SCHEMBL1403636 | 1.00 | PGD (0.53) | PGDMPILMNAL3MBTL1PGK1 | |
| SCHEMBL20817087 | 1.00 | PGD (0.53) | PGDMPILMNAL3MBTL1PGK1 | |
| SCHEMBL3748606 | 1.00 | PGD (0.53) | PGDMPILMNAL3MBTL1PGK1 | |
| SCHEMBL18585436 | 0.98 | PGD (0.52) | PGDMPILMNAL3MBTL1PGK1 | |
| Phosphoric Acid SCHEMBL3010369 | 0.98 | PGD (0.52) | PGDMPILMNAL3MBTL1PGK1 | |
| SCHEMBL2293262 | 0.98 | PGD (0.52) | PGDMPILMNAL3MBTL1PGK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 419 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118599793-A | Sorbitol-6-phosphate dehydrogenase mutant and application thereof in synthesis of sorbitol-6-phosphate | 华东理工大学 | 2024-09-06 | — | — | CN | claimed |
| CN-113624862-B | Metabolome covering multiple metabolites, metabolic flux analysis method and kit | 清华大学 | 2023-04-07 | — | — | CN | claimed |
| US-20170281772-A1 | A NEURAL SUBSTRATE FOR SUGAR PREFERENCE | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2017-10-05 | — | — | US | claimed |
| EP-3194416-A1 | A NEURAL SUBSTRATE FOR SUGAR PREFERENCE | The Trustees of Columbia University in the City of New York (US) | 2017-07-26 | — | — | EP | claimed |
| US-20160245814-A1 | BIOMARKERS FOR KIDNEY CANCER AND METHODS USING THE SAME | METABOLON, INC. | 2016-08-25 | — | — | US | claimed |
| WO-2016044756-A1 | A NEURAL SUBSTRATE FOR SUGAR PREFERENCE | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2016-03-24 | — | — | WO | claimed |
| WO-2015050783-A1 | BIOMARKERS FOR KIDNEY CANCER AND METHODS USING THE SAME | METABOLON, INC. (US) | 2015-04-09 | — | — | WO | claimed |
| US-5843750-A | Sorbitol kinase, process for producing the same, and substantially pure microorganism | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1998-12-01 | — | — | US | claimed |
| EP-0784092-A1 | SORBITOL KINASE, PROCESS FOR PRODUCING THE SAME, AND SUBSTANTIALLY PURE MICROORGANISM | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1997-07-16 | — | — | EP | claimed |
| JP-8103270-A | — | — | None | — | — | JP | disclosed |
| JP-8103268-A | — | — | None | — | — | JP | disclosed |
| JP-8103268-A | — | — | None | — | — | JP | disclosed |
| CN-122095083-A | Genetically modified yeasts and fermentation processes for the production of xylitol | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260125713-A1 | PRODUCTION OF MOLECULES BY PERIPLASMIC ENZYMATIC CATALYSIS | BIOC3 (FR) | 2026-05-07 | — | — | US | disclosed |
| WO-1992003122-A1 | PREPARATION FOR APPLICATION OF ACTIVE SUBSTANCES IN THE FORM OF MINIMUM-SIZED DROPLETS | CEVC GREGOR (DE) | 1992-03-05 | — | — | WO | disclosed |
| US-4939146-A | Administering a primary aliphatic alcohol | DUKE UNIVERSITY | 1990-07-03 | — | — | US | disclosed |
| US-4726943-A | ALKOXYLATED TRIHYDRIC TO HEXAHYDRIC ALIPHATIC POLYCOL WHEREIN AT LEAST ON HYDROXYL MOIETY IS ESTERIFIED WITH PHOSPHORIC ACID | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1988-02-23 | — | — | US | disclosed |
| US-4348381-A | Dental remineralization composition | COLGATE-PALMOLIVE COMPANY (US) | 1982-09-07 | — | — | US | disclosed |
| US-4183915-A | Stable solution for dental remineralization | COLGATE-PALMOLIVE COMPANY (US) | 1980-01-15 | — | — | US | disclosed |
| US-4177258-A | Dentifrice for dental remineralization | COLGATE PALMOLIVE COMPANY (US) | 1979-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125713-A1 | PRODUCTION OF MOLECULES BY PERIPLASMIC ENZYMATIC CATALYSIS | MGAM, MRPL21, NOTUM | PGD 106/4885MPI 469/4885LMNA 3912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.